Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs)
Version of Record online: 22 JUN 2012
Copyright © 2012 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 22, Issue 10, pages 1130–1133, October 2013
How to Cite
Krska, J. (2013), Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs). Pharmacoepidem. Drug Safe., 22: 1130–1133. doi: 10.1002/pds.3306
- Issue online: 1 OCT 2013
- Version of Record online: 22 JUN 2012
- Manuscript Accepted: 16 MAY 2012
- Manuscript Revised: 1 MAY 2012
- Manuscript Received: 13 FEB 2012
- patient reporting;
- community pharmacist;
- Yellow Card Scheme;
- adverse drug reaction;
To survey British community pharmacists’ views and practices concerning direct patient reporting of ADRs.
Cross-sectional postal survey of community pharmacists in Britain
Of 1096 questionnaires distributed, 297 usable responses were obtained, (27.1%). Respondents’ estimates of the frequency of patients reporting a suspected ADR to them had a median of 1.0 per month. Almost a fifth of respondents (19.6%) do not specifically ask patients about ADRs, and 38.7% do not encourage patients to report.
Only 18.5% displayed a poster promoting the YC Scheme in their pharmacy, but 57.9% claimed to have patient YCs available. A quarter (24.9%) of respondents considered that ADR reporting should be restricted to health professionals and 14.4% considered that patients were not at all capable of identifying ADRs.
The low response rate and overall results suggest that British community pharmacists may lack interest in and do not promote direct patient reporting. Increased awareness of the benefits and mechanisms of patient reporting may be required to ensure that pharmacists can provide the necessary support to facilitate patient reporting. Copyright © 2012 John Wiley & Sons, Ltd.